0000885725-22-000004.txt : 20220215 0000885725-22-000004.hdr.sgml : 20220215 20220215161944 ACCESSION NUMBER: 0000885725-22-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220214 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220215 DATE AS OF CHANGE: 20220215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 22639428 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 8-K 1 bsx-20220214.htm 8-K bsx-20220214
0000885725false00008857252022-02-142022-02-140000885725us-gaap:CommonStockMember2022-02-142022-02-140000885725bsx:SeniorNotedue2027Member2022-02-142022-02-140000885725bsx:A550MCPSSeriesAMember2022-02-142022-02-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
_____________________________________________________________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 
_____________________________________________________________________


Date of Report (Date of earliest event reported): February 15, 2022 (February 14, 2022)

BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in its charter)
Delaware1-1108304-2695240
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)

    300 Boston Scientific Way, Marlborough, Massachusetts                    01752-1234
        (Address of Principal Executive Offices)                          (Zip Code)

Registrant's telephone number, including area code:   508 683-4000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.01 par value per shareBSXNew York Stock Exchange
0.625% Senior Notes due 2027BSX27New York Stock Exchange
5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per shareBSX PR ANew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company   ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐





ITEM 8.01 OTHER EVENTS.

On February 14, 2022, Boston Scientific Corporation (the “Company”) completed its acquisition of Baylis Medical Company, Inc. (“Baylis Medical”), a privately-held company which has developed the NRG® and VersaCross® transseptal radiofrequency (RF) platforms as well as a family of guidewires, sheaths and dilators used to support left heart access. The transaction price consisted of an upfront payment of $1.75 billion and is expected to be approximately one cent accretive to adjusted earnings per share (EPS) in 2022 and increasingly accretive thereafter. On a GAAP basis, the transaction is expected to be less accretive, or dilutive, in 2022 and less dilutive or increasingly accretive, as the case may be, thereafter, due to amortization expense and acquisition-related net charges.

A copy of the Company's press release announcing the completion of the acquisition of Baylis Medical is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference; provided, however, that information on or connected to our website or the website of any third-party hyperlinked from or referenced in the Company's press release included as Exhibit 99.1 to this Current Report on Form 8-K is expressly not incorporated by reference into or intended to be filed as a part of this Current Report on Form 8-K.

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend” and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our business plans, regulatory approvals, product development and performance, and impact of acquisitions on our results of operations. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

Use of Non-GAAP Financial Measures

To supplement our consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income and adjusted net income (earnings) per share that excludes certain charges and/or credits, such as amortization expense and acquisition-related net charges (credits). These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. For further information regarding our non-GAAP measures, see Part II, Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations in our most recent Annual Report on Form 10-K, which we may update in Quarterly Reports on Form 10-Q we have filed or will file hereafter.






ITEM 9.01.     FINANCIAL STATEMENTS AND EXHIBITS.

(d)  Exhibits


Exhibit No.        Description

104            Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL
            document




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
                        
                                
Date:February 15, 2022BOSTON SCIENTIFIC CORPORATION
By:/s/ Vance R. Brown
Vance R. Brown
Senior Vice President, General Counsel & Corporate Secretary


 EX-99.1 2 exhibit991february152022pr.htm EX-99.1 Document

image.jpg

Boston Scientific Closes Acquisition of Baylis Medical Company Inc.


MARLBOROUGH, Mass., February 15, 2022– Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Baylis Medical Company Inc., a company that offers advanced transseptal access solutions as well as guidewires, sheaths and dilators used to support catheter-based left-heart procedures.

“The close of this acquisition allows Boston Scientific to integrate the Baylis platforms with our existing electrophysiology and structural heart offerings, further strengthening our position within the highest growth cardiology markets,” said Joe Fitzgerald, executive vice president and president, Cardiology, Boston Scientific. “We are now the only company to pair a comprehensive access portfolio with existing left-heart therapies such as left atrial appendage closure and atrial fibrillation ablation, providing physicians with a complete toolbox to treat patients with safety, efficacy and efficiency.”

The transaction consists of an upfront payment of $1.75 billion, and is expected to be approximately one cent accretive to adjusted earnings per share in 2022 and increasingly accretive thereafter. On a GAAP basis, the transaction is expected to be less accretive, or dilutive, in 2022 and less dilutive or increasingly accretive, as the case may be, thereafter, due to amortization expense and acquisition-related net charges.

Additional information about this transaction is available on the Events and Presentations section of the Boston Scientific investor relations website.


About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.


Cautionary Statement Regarding Forward-Looking Statements


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our business plans, clinical trials and product performance and impact. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.



Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACTS:
Angela Mineo
Media Relations
(763) 955-8325 (office)
Angela.mineo@bsci.com

Lauren Tengler
Investor Relations
(508) 683-4479
BSXInvestorRelations@bsci.com


 EX-101.SCH 3 bsx-20220214.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Document link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 bsx-20220214_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 bsx-20220214_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 5.50% MCPS, Series A [Member] 5.50% MCPS, Series A [Member] 5.50% MCPS, Series A Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Information [Line Items] Entity Information [Line Items] Document Period End Date Document Period End Date Entity Central Index Key Entity Central Index Key Senior Note due 2027 [Member] Senior Note due 2027 [Member] Senior Note due 2027 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Common Stock [Member] Common Stock [Member] Entity Registrant Name Entity Registrant Name Entities [Table] Entities [Table] Written Communications Written Communications Local Phone Number Local Phone Number Soliciting Material Soliciting Material Entity Address, State or Province Entity Address, State or Province City Area Code City Area Code Document Type Document Type Class of Stock [Domain] Class of Stock [Domain] Cover page. Cover [Abstract] Entity Address, City or Town Entity Address, City or Town Class of Stock [Axis] Class of Stock [Axis] Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Amendment Flag Amendment Flag Trading Symbol Trading Symbol Entity Tax Identification Number Entity Tax Identification Number EX-101.PRE 6 bsx-20220214_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 image.jpg begin 644 image.jpg MB5!.1PT*&@H -24A$4@ ! H "6" 8 !73VH' 7-21T( KLX< MZ0 1G04U! "QCPO\804 )<$A9

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�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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover Document
Feb. 14, 2022
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Feb. 14, 2022
Entity Registrant Name BOSTON SCIENTIFIC CORPORATION
Amendment Flag false
Entity Incorporation, State or Country Code DE
Entity File Number 1-11083
Entity Tax Identification Number 04-2695240
Entity Address, Address Line One 300 Boston Scientific Way
Entity Address, City or Town Marlborough
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01752-1234
City Area Code 508
Local Phone Number 683-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000885725
Common Stock [Member]  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol BSX
Security Exchange Name NYSE
Senior Note due 2027 [Member]  
Entity Information [Line Items]  
Title of 12(b) Security 0.625% Senior Notes due 2027
Trading Symbol BSX27
Security Exchange Name NYSE
5.50% MCPS, Series A [Member]  
Entity Information [Line Items]  
Title of 12(b) Security 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share
Trading Symbol BSX PR A
Security Exchange Name NYSE

XML 9 bsx-20220214_htm.xml IDEA: XBRL DOCUMENT 0000885725 2022-02-14 2022-02-14 0000885725 us-gaap:CommonStockMember 2022-02-14 2022-02-14 0000885725 bsx:SeniorNotedue2027Member 2022-02-14 2022-02-14 0000885725 bsx:A550MCPSSeriesAMember 2022-02-14 2022-02-14 0000885725 false 8-K 2022-02-14 BOSTON SCIENTIFIC CORPORATION DE 1-11083 04-2695240 300 Boston Scientific Way Marlborough MA 01752-1234 508 683-4000 false false false false Common Stock, $0.01 par value per share BSX NYSE 0.625% Senior Notes due 2027 BSX27 NYSE 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share BSX PR A NYSE false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 4 122 1 false 3 0 false 0 false false R1.htm 0001001 - Document - Cover Document Sheet http://www.bostonscientific.com/role/CoverDocument Cover Document Cover 1 false false All Reports Book All Reports bsx-20220214.htm bsx-20220214.xsd bsx-20220214_def.xml bsx-20220214_lab.xml bsx-20220214_pre.xml exhibit991february152022pr.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bsx-20220214.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "bsx-20220214_def.xml" ] }, "inline": { "local": [ "bsx-20220214.htm" ] }, "labelLink": { "local": [ "bsx-20220214_lab.xml" ] }, "presentationLink": { "local": [ "bsx-20220214_pre.xml" ] }, "schema": { "local": [ "bsx-20220214.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 2, "memberStandard": 1, "nsprefix": "bsx", "nsuri": "http://www.bostonscientific.com/20220214", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bsx-20220214.htm", "contextRef": "i0e2e6ce94bc242688895e12edc1ac99f_D20220214-20220214", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Document", "role": "http://www.bostonscientific.com/role/CoverDocument", "shortName": "Cover Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bsx-20220214.htm", "contextRef": "i0e2e6ce94bc242688895e12edc1ac99f_D20220214-20220214", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "bsx_A550MCPSSeriesAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "5.50% MCPS, Series A", "label": "5.50% MCPS, Series A [Member]", "terseLabel": "5.50% MCPS, Series A [Member]" } } }, "localname": "A550MCPSSeriesAMember", "nsuri": "http://www.bostonscientific.com/20220214", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "domainItemType" }, "bsx_SeniorNotedue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Note due 2027 [Member]", "label": "Senior Note due 2027 [Member]", "terseLabel": "Senior Note due 2027 [Member]" } } }, "localname": "SeniorNotedue2027Member", "nsuri": "http://www.bostonscientific.com/20220214", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.bostonscientific.com/role/CoverDocument" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0000885725-22-000004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000885725-22-000004-xbrl.zip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end